Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prevasil
- Development stage
- Unknown
- Lead developer
- Bolm
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Prevasil** is a Bōlm topical over-the-counter cold-sore product line containing **synthetic camphor 3.1%** and **thymol 0.13%** as external analgesic active ingredients. It is supplied as a gel and as a lip-balm stick for temporary relief of pain and itching associated with cold sores and fever blisters; the lip balm is also labeled to help protect and relieve chapped or cracked lips. Camphor and thymol provide local soothing, cooling, and counterirritant analgesic effects rather than a targeted antiviral treatment for herpes simplex virus. The products are listed as human OTC drugs under an OTC monograph and are marketed by Bōlm.
- Brand names
- PrevasilPrevasil Ultra Care Lip Balm
Beyond the preview
Go deeper on Prevasil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prevasil.